NCT00963820View on ClinicalTrials.gov

Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

January 31, 2014

Conditions
Multiple Myeloma
Interventions
DRUG

Ixazomib citrate

Ixazomib citrate capsules

Trial Locations (6)

10011

Weill-Cornell Medical College, New York

55905

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

85259

Mayo Clinic- Scottsdale, Scottsdale

90069

James R. Berenson, MD, Inc, West Hollywood

98109

Fred Hutchinson Cancer Research Center, Seattle

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY